Why Sorrento Therapeutics Stock Plunged Today
Shares of Sorrento Therapeutics (NASDAQ: SRNE) fell on Wednesday after the biopharmaceutical company fired its chief financial officer. By the close of trading, Sorrento's stock was down 9.9%.
After the market close on Tuesday, Sorrento disclosed in a Securities and Exchange Commission (SEC) filing that it had terminated CFO Jiong Shao's employment, effective immediately.
Source Fool.com